Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ARQT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Masaru Matsuda EVP, Chief Legal Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 40,000 | $34.32 | $1.4M Sale | Form 4 ↗ |
| Nov 2, 2026 | Masaru Matsuda EVP, Chief Legal Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,219 | $31.86 | $38.8K Sale | Form 4 ↗ |
| Nov 2, 2026 | Patrick Burnett EVP, Chief Medical Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 943 | $31.86 | $30.0K Sale | Form 4 ↗ |
| Nov 2, 2026 | Todd Watanabe See Remarks, Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,377 | $31.86 | $139.5K Sale | Form 4 ↗ |
| Oct 15, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,728 | $26.93 | $127.3K Sale | Form 4 ↗ |
| Sep 16, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 3,674 | $25.00 | $91.8K Sale | Form 4 ↗ |
| Sep 15, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,730 | $24.18 | $114.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 9,989 | $25.03 | $250.0K Sale | Form 4 ↗ |
| Aug 27, 2026 | Terrie Curran Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 27,052 | $25.03 | $677.1K Sale | Form 4 ↗ |
| Aug 27, 2026 | Terrie Curran Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 11,148 | $25.03 | $279.0K Sale | Form 4 ↗ |
| Aug 20, 2026 | Terrie Curran Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,072 | $26.04 | $27.9K Sale | Form 4 ↗ |
| Aug 19, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,697 | $27.00 | $45.8K Sale | Form 4 ↗ |
| Aug 17, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,730 | $26.18 | $123.8K Sale | Form 4 ↗ |
| Aug 12, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 6,700 | $26.08 | $174.7K Sale | Form 4 ↗ |
| Aug 11, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 8,300 | $26.52 | $220.1K Sale | Form 4 ↗ |
| Aug 3, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 955 | $26.12 | $24.9K Sale | Form 4 ↗ |
| Aug 3, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,230 | $26.12 | $32.1K Sale | Form 4 ↗ |
| Aug 3, 2026 | Todd Watanabe See Remarks, Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,375 | $26.12 | $114.3K Sale | Form 4 ↗ |
| Jul 15, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,730 | $26.91 | $127.3K Sale | Form 4 ↗ |
| Jun 17, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 635 | $25.67 | $16.3K Sale | Form 4 ↗ |
| Jun 15, 2026 | Sue-Jean Lin Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,946 | $24.38 | $120.6K Sale | Form 4 ↗ |
| Jun 15, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,096 | $24.41 | $100.0K Sale | Form 4 ↗ |
| May 11, 2026 | Latha Vairavan SVP Chief Financial Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 435 | $21.05 | $9,157 Sale | Form 4 ↗ |
| May 11, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 222 | $21.05 | $4,673 Sale | Form 4 ↗ |
| May 4, 2026 | Latha Vairavan SVP Chief Financial Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,341 | $23.61 | $31.7K Sale | Form 4 ↗ |
| May 4, 2026 | Todd Watanabe See Remarks, Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 3,172 | $23.61 | $74.9K Sale | Form 4 ↗ |
| May 4, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 884 | $23.61 | $20.9K Sale | Form 4 ↗ |
| May 4, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 7,372 | $23.27 | $171.5K Sale | Form 4 ↗ |
| May 4, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 684 | $23.61 | $16.1K Sale | Form 4 ↗ |
| May 1, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 7,144 | $22.99 | $164.2K Sale | Form 4 ↗ |
| Apr 1, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 10,000 | $23.88 | $238.8K Sale | Form 4 ↗ |
| Mar 2, 2026 | Keith R. Leonard Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 39,272 | $25.39 | $997.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | Howard G. Welgus Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 10,000 | $25.65 | $256.5K Sale | Form 4 ↗ |
| Mar 2, 2026 | Larry Todd Edwards See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 103 | $25.91 | $2,669 Sale | Form 4 ↗ |
| Mar 2, 2026 | Larry Todd Edwards See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 3,584 | $25.16 | $90.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Todd Watanabe See Remarks, Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,068 | $25.91 | $27.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Todd Watanabe See Remarks, Director | ARQT Arcutis Biotherapeutics, Inc. | Sale | 36,281 | $25.16 | $912.8K Sale | Form 4 ↗ |
| Mar 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 1,987 | $25.70 | $51.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 193 | $25.91 | $5,001 Sale | Form 4 ↗ |
| Mar 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 6,553 | $25.16 | $164.9K Sale | Form 4 ↗ |
| Mar 2, 2026 | Latha Vairavan SVP Chief Financial Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 81 | $25.91 | $2,099 Sale | Form 4 ↗ |
| Mar 2, 2026 | Latha Vairavan SVP Chief Financial Officer | ARQT Arcutis Biotherapeutics, Inc. | Sale | 2,772 | $25.16 | $69.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 181 | $25.91 | $4,690 Sale | Form 4 ↗ |
| Mar 2, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 6,106 | $25.16 | $153.6K Sale | Form 4 ↗ |
| Feb 27, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 3,325 | $27.95 | $92.9K Sale | Form 4 ↗ |
| Feb 4, 2026 | Patrick Burnett See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 9,794 | $25.81 | $252.8K Sale | Form 4 ↗ |
| Feb 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 4,714 | $25.63 | $120.8K Sale | Form 4 ↗ |
| Feb 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 19,379 | $25.24 | $489.1K Sale | Form 4 ↗ |
| Feb 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 8,562 | $24.97 | $213.8K Sale | Form 4 ↗ |
| Feb 2, 2026 | Masaru Matsuda See Remarks | ARQT Arcutis Biotherapeutics, Inc. | Sale | 7,983 | $25.50 | $203.6K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances